The Hypothalamo‐Pituitary‐Adrenal Axis in Multiple Sclerosis
- 1 May 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 992 (1) , 118-128
- https://doi.org/10.1111/j.1749-6632.2003.tb03143.x
Abstract
During multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS), activation of the hypothalamo-pituitary-adrenal (HPA) axis is considered to modulate the immune system in such a way that the probability of recovery from a relapse is increased. In a series of postmortem studies we observed a significant activation of corticotropin releasing hormone (CRH) neurons and increased cortisol in the cerebrospinal fluid (CSF) of MS patients, indicating activation of the HPA axis in this disease. On the other hand, sepsis, while elevating cortisol in control subjects, did not associate with a further increase of cortisol in MS patients. Thus, the activated HPA-system in MS does not respond to an acute inflammatory stimulus. In order to investigate the role of chronic inflammation in the CNS in the activation of the HPA axis in MS, MS lesions in the hypothalamus were quantified and interleukin (IL)-6 levels in the CSF were determined. There was no difference in IL-6 levels between MS and control patients. A positive correlation was found between cortisol and IL-6 in control subjects with sepsis, but not in MS patients with sepsis or MS and control groups without sepsis. Thus, IL-6 in the CSF of MS patients is not the cause of the activation of the HPA system in MS. We found a remarkably high incidence (95% of the patients) of MS lesions in the hypothalamus, of which the majority (60%) were active. The more active lesions were present in the hypothalamus, the shorter the disease duration to the moment of death, indicative of a worse disease course. Preliminary data show suppression of the activation of CRH neurons by active hypothalamic MS lesions. We propose that this suppression of CRH neurons by active hypothalamic MS lesions causes the concomitant unfavorable disease course via an inadequate cortisol response during relapses of MS.Keywords
This publication has 30 references indexed in Scilit:
- Effect of Repeated Lipopolysaccharide Administration on Tissue Cytokine Expression and Hypothalamic‐Pituitary‐Adrenal Axis Activity in RatsJournal of Neuroendocrinology, 2001
- Disease Progression in Chronic Relapsing Experimental Allergic Encephalomyelitis Is Associated with Reduced Inflammation-Driven Production of CorticosteroneEndocrinology, 2001
- Duration of Glucocorticoid Treatment and Outcome in SepsisChest, 1998
- Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosisJournal of Neuroimmunology, 1995
- Increased Cortisol Levels in Aging and Alzheimer's Disease in Postmortem Cerebrospinal FluidJournal of Neuroendocrinology, 1994
- Multiple sclerosis is associated with alterations in hypothalamic- pituitary-adrenal axis functionJournal of Clinical Endocrinology & Metabolism, 1994
- Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humansJournal of Clinical Endocrinology & Metabolism, 1993
- Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory systemProgress in Neurobiology, 1993
- Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory diseaseImmunology Today, 1991
- Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.The Journal of Experimental Medicine, 1989